COX-2 immunoreactivity was also observed in the cytoplasm in all CRC cases, with 55 cases low expression (10% COX-2, Fig. 1c) and 63 cases high expression (80% COX-2, Fig. 1f). Here, PTGS2 is linked to colorectal carcinoma.